AI is already helping pharmaceutical R&D teams find products, review purchasing data, and make faster sourcing decisions. Agentic AI takes the next step. Instead of only suggesting what to do, it can help move an approved request through several parts of the procurement process.
A single lab purchase can touch product specifications, preferred suppliers, contract pricing, inventory data, budgets, approvals, enterprise systems, and delivery schedules. AI can help connect those pieces, but it still needs reliable information, clear rules, and people who know when a decision requires scientific or commercial judgment.
What is agentic AI in procurement?
Agentic AI in procurement uses AI agents to understand a goal, decide what steps are needed, and take permitted actions across a purchasing workflow. Traditional automation follows a fixed rule. An agent can respond to the situation in front of it and coordinate work across systems.
Suppose a researcher needs a reagent by Friday. An agent could clarify the request, check approved products and suppliers, compare availability and contract terms, route the purchase for approval, and monitor the order. If the product is unavailable and a substitute could affect the experiment, it would bring a person into the decision.
That is the central idea: let AI handle routine coordination, but not decisions that require scientific, commercial, or compliance judgment.
How is agentic AI different from generative AI and procurement automation?
Generative AI, procurement automation, and agentic AI can support the same process, but they play different roles.
| Technology | Primary function | Procurement example |
|---|---|---|
| Generative AI | Creates or summarizes content in response to a prompt | Summarizing supplier information or drafting an RFQ |
| Procurement automation | Executes a predefined rule or task | Routing a requisition according to a fixed approval threshold |
| Agentic AI | Plans and coordinates multiple actions toward an objective | Evaluating a request, selecting an approved purchasing path, coordinating approvals, and monitoring fulfillment |
Making one task faster does not necessarily fix the full process. As explained in procurement automation vs. procurement orchestration, researchers and procurement teams can still end up managing the gaps between isolated systems.
Agentic AI becomes more useful when those systems are connected.
It also points to the need for strong data, security, system compatibility, oversight, and clear controls.
Where can AI agents help pharmaceutical procurement?
The best starting points are likely to be frequent tasks with clear goals, dependable data, and an obvious point at which a person should step in.
| Workflow stage | How an agent could help | When a person should step in |
|---|---|---|
| Request intake | Translate scientific needs into purchasing criteria | Ambiguous or incomplete specifications |
| Product evaluation | Compare approved products, suppliers, pricing, and availability | Scientifically consequential substitution |
| Policy application | Apply preferred-supplier and purchasing rules | Out-of-policy request |
| Approvals | Route requests and assemble supporting information | High-value or unusual purchase |
| Fulfillment | Monitor delays and identify approved options | Change that could affect research |
| System updates | Record actions and return structured data | Missing or conflicting records |
- Interpret scientific purchasing requests. An agent could translate a protocol, technical specification, brand preference, quantity, or deadline into structured purchasing criteria. This extends the product-discovery capabilities discussed in AI in lab procurement into subsequent workflow steps.
- Evaluate approved purchasing options. An agent could compare specifications, supplier status, contract pricing, availability, delivery dates, site rules, and purchasing history. A person should review choices involving purity, grade, formulation, documentation, instrument compatibility, storage, or experimental continuity.
- Apply procurement policies during selection. An agent could recommend preferred suppliers, flag out-of-policy requests, identify required documentation, or choose the correct buying channel. This extends guided buying beyond product selection.
- Coordinate approvals and exceptions. An agent could assemble supporting information, route a request, and follow up when action is overdue. Exceptions should reach the appropriate procurement, legal, safety, or scientific reviewer.
- Monitor fulfillment and respond to changes. An agent could monitor delivery changes, backorders, partial shipments, and invoice discrepancies, then alert stakeholders or identify approved options. Researchers should control consequential substitutions.
- Return structured information to enterprise systems. Agents should record decisions, approvals, exceptions, and transactions in the appropriate ERP, P2P, finance, supplier, inventory, or research system rather than create another isolated information layer.
Why does pharmaceutical R&D need tighter controls?
Scientific purchasing involves more than price, service, and contract terms. Technical details can determine whether a product is suitable for the work.
Two products may appear comparable while differing in concentration, purity, grade, formulation, validation, storage, shelf life, or instrument compatibility. Substituting one for another could affect an experiment, introduce repeat work, or interrupt a research timeline.
Pharmaceutical organizations also work across multiple sites, supplier networks, and enterprise systems. An agent needs scientific context as well as commercial data, and it needs clear limits on what it can decide on its own.
Which decisions should stay with people?
AI agents are best suited to decisions that happen often, follow clear rules, and can be explained or reversed. People should stay closely involved when a decision could affect research, compliance, supplier risk, or a significant amount of money.
Examples include:
- Approving a product substitution that could alter experimental results
- Qualifying a new or high-risk supplier
- Interpreting ambiguous scientific requirements
- Authorizing unusual, high-value, or out-of-policy purchases
- Reviewing controlled, hazardous, or specially regulated materials
- Resolving conflicts between cost, timing, compliance, and research continuity
- Changing the policies or objectives that govern agent behavior
Oversight goes beyond approving individual purchases. Teams need to know what an agent can access, which actions it can take, why it made a recommendation, when it must ask for help, and how its performance will be checked.
The NIST AI Risk Management Framework offers a useful model organized around four functions: govern, map, measure, and manage. It is not specific to procurement, but it can help teams assign responsibility and manage risk throughout an AI system's lifecycle.
A simple test for deciding what AI should handle
Before assigning a decision to an agent, ask four questions:
- Is the decision repeatable?
- Is the necessary data dependable?
- Can the action be reversed?
- Is the escalation owner clear?
The more often the answer is yes, the better the workflow may be suited to an AI agent. A no does not rule out AI assistance. It simply means a person should stay more directly involved.
What needs to be in place first?
Before an agent can take meaningful action, several basics need to be in place.
Why procurement orchestration matters
The value of agentic AI is not another chat window. It is the ability to coordinate work across people and systems.
Scientific Procurement Orchestration connects researchers, suppliers, procurement policies, purchasing data, and enterprise systems. That gives AI the information and connections needed to support a request from initial need through approval, ordering, delivery, and financial processing.
AI can then interpret, coordinate, and act within defined boundaries while procurement leaders maintain control over policies, suppliers, budgets, exceptions, and risk.
How pharmaceutical organizations can get started
Organizations do not need to tackle the entire procurement lifecycle at once. Starting with one clear problem is more practical.
What agentic AI could mean for pharmaceutical R&D
The next stage of AI in pharmaceutical procurement goes beyond a more conversational search bar. It can help coordinate work across scientific requirements, procurement policies, suppliers, approvals, and enterprise systems.
Its value will depend on reliable data, clear rules, connected workflows, and people who remain involved in consequential decisions. The goal is not autonomous purchasing at any cost. It is less time spent coordinating routine work, faster decisions when issues arise, and more time for science.
Frequently asked questions about agentic AI in procurement
- What is agentic AI in procurement?
Agentic AI in procurement uses AI agents to understand a purchasing need, plan the next steps, and take approved actions across a workflow. An agent might apply policies, coordinate approvals, update connected systems, and bring exceptions to the right person. - How is agentic AI different from procurement automation?
Procurement automation follows predefined tasks or rules. Agentic AI can assess the situation, choose among approved actions, and coordinate several steps. Both still need reliable data, clear permissions, and human oversight. - Can AI agents make pharmaceutical purchasing decisions independently?
AI agents can handle routine decisions when the data, rules, and permissions are clear. People should review scientific substitutions, supplier qualification, regulatory concerns, unusual risks, and purchases with significant financial consequences. - What procurement workflows are best suited to AI agents?
The best candidates are frequent, rules-based workflows supported by reliable data and a clear path for exceptions. Request intake, policy checks, approval coordination, order monitoring, and status updates may be good places to start.
Give researchers a faster path from need to order with agentic AI
Find out how ZAGENO uses agentic AI to help researchers find the right products, follow approved purchasing paths, and keep orders moving, while procurement retains visibility and control.
Related resources
